Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency

Blood

Volumn 91, Issue 2, 1998, Pages 706-709

  Cocco, Pierluigi ^a   Todde, Pierfelice ^b   Fornera, Susanna ^b   Manca, Maria Bonaria ^b   Manca, Pierina ^b   Sias, Ana Rosa ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031982856     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.706.706_706_709     Document Type: Article

References (34)

1. Luzzato L, Metha A: Glucose-6-phosphate dehydrogenase deficiency, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Diseases (ed 6). New York, NY, McGraw Hill, 1989, p 2237
2. Beutler E: G6PD deficiency. Blood 84:3613, 1994
3. Dessì S, Batetta B, Laconi E, Ennas C, Pani P: Hepatic cholesterol in lead nitrate-induced liver hyperplasia. Chem Biol Interact 48:271, 1984
4. Rao KN, Kattapally S, Shinozuka H: Acinar cell carcinoma of rat pancreas: Mechanism of deregulation of cholesterol metabolism. Toxicol Pathol 12:62, 1984
5. Laconi E, Dessí S, Batetta B, Pani P, Pirisi L, Andria C, Macciotta A: Effect of phenobarbital treatment on erythrocyte glucose-6-phosphate dehydrogenase in human newborns. Pediatr Pharmacol 3:59, 1983
6. Nebert DW: Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can cope with adversity. Mol Cell Biochem 27:27, 1979
7. Neal GE, Moss EJ, Manson MM: Glutathione conjugation in oncogenesis, in Sies H, Ketterer B (eds): Glutathione Conjugation: Mechanisms and Biological Significance. New York, NY, Academic, 1988, p 281
8. Siniscalco M, Bernini L, Latte B, Motulski AG: Favism and thalassemia and their relationship to malaria. Nature 190:1179, 1961
9. Cocco PL, Manca P, Dessì S: Preliminary results of a geographic correlation study on G6PD deficiency and cancer. Toxicol Pathol 15:106, 1987
10. Long WK, Wilson SW, Frenkel EP: Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. Am J Hum Genet 19:35, 1967
11. Sulis E, Spano G: Osservazioni preliminari sull'incidenza e sul comportamento enzimatico e proliferativo del tessuto tumorale negli individui carenti di glucosio-6-fosfato deidrogenasi. Boll Soc It Biol Sper 44:271, 1968
12. Naik SN, Anderson DE: The association between glucose-6-phosphate dehydrogenase deficiency and cancer in American Negroes. Oncology 25:356, 1971
13. Beutler E, Mitchell M: Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood 32:816, 1968
14. International Classification of Diseases. 1975 Revision. Geneva, Switzerland, World Health Organization, 1977
15. Liddell FDK: Simple exact analysis of the standardized mortality ratio. J Epidemiol Commun Health 38:85,1984
16. Wiesenfeld SL, Petrakis NL, Sams BJ, Collen MF, Cutler JL: Elevated blood pressure, pulse rate, and serum creatinine in Negro males deficient in glucose-6-phosphate dehydrogenase. N Engl J Med 282:1001, 1970
17. Rao KN: The significance of the cholesterol biosynthesis pathway in cell growth and carcinogenesis (review). Anticancer Res 15:309, 1995
18. Cocco PL: Does G6PD deficiency protect against cancer? A critical review. J Epidemiol Commun Health 41:89, 1987
19. Ramot B, Szeinberg A, Adam A, Sheba C, Gafni D: A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: Investigation on platelets enzymes. J Clin Invest 30:1659, 1959
20. Ramot B, Szeinberg A, Adam A, Sheba C, Gafni D: A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: Investigation on leucocytic enzymes. J Clin Invest 30:2234, 1959
21. Panizon F: Studio sull'attivita' enzimatica della mucosa digiunate in soggetti con G6PD-penia eritrocitaria. Studi Sassaresi 39:710, 1961
22. Pannaciulli I, Tizianello A, Salvidio E: L'attivita' della G6PD e 6PGD dei leucociti, delle piastrine, delle cellule midollari, spleniche, epatiche e di tessuto gastrico in soggetti con eritroenzimopenia familiare. Boll Soc Ital Biol Sper 42:1552, 1966
23. Wissler RW, Vesselinovitch D, Davis HR: Cellular components of the progressive atherosclerotic process, in Olsson AG (ed): Atherosclerosis. Biology and Clinical Science. Edinburgh, UK, Churchill Livingstone, 1987, p 57
24. Wallace MN: NADPH diaphorase activity in activated astrocytes representing inducible nitric oxide synthase, in Packer L (ed): Methods in Enzymology, vol 268. Nitric Oxide, Part A. Sources and Detection of NO; NO Synthase. San Diego, CA, Academic, 1996, p 497
25. Wink DA, Nims RW, Darbyshire JF, Christodoulou D, Hanbauer I, Cox GW, Laval F, Laval J, Cook JA, Krishna MC, DeGraff WG, Mitchell JB: Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol 7:519, 1994
26. Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345:161, 1990
27. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90:9813, 1993
28. Hogg N, Kalyanaraman B, Joy J, Struck A, Parthasarathy S: Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334:170, 1993
29. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109, 1991
30. Cocco PL, Dessì S, Avataneo G, Picchiri GF, Heineman EF: Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: A case-control study. Carcinogenesis 10:813, 1989
31. Pisano M, Cocco PL, Cherchi R, Onnis R, Cherchi PP: Glucose-6-phosphate dehydrogenase deficiency and lung cancer: A hospital based case-control study. Tumori 77:12, 1991
32. Ferraris AM, Broccia G, Meloni T, Forteleoni G, Gaetani GF: Glucose-6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy. Am J Hum Genet 42:516, 1988
33. Axelson O, Steenland K: Indirect methods of assessing the effects of tobacco use in occupational studies. Am J Ind Med 13:105, 1988
34. Thurman RG, Classman EB, Handler JA, Forman DT; The swift increase in alcohol metabolism (SIAM): A commentary on the regulations of alcohol metabolism in mammals, in Crow KE, Batt RD (eds): Human Metabolism of Alcohol. Volume II: Regulation, Enzymology, and Metabolites of Ethanol. Boca Raton, FL, CRC, 1989,p 17